Clinical research organisation (CRO) Emmes has unveiled a dedicated centre to expand its cell and gene therapy research.
The new centre will offer research services in clinical trial operations, study leadership, statistical services, data management, and pharmacovigilance.
Adam Mendizabal has been named the scientific leader of the Cell and Gene Therapy Center.
Mendizabal said: “Innovations in cell and gene therapies are accelerating the opportunity to tackle increasingly complex research questions. Ultimately, what this means is greater potential to test and create life-changing treatments for patients suffering from a wide range of conditions and diseases. “
Emmes has partnered with the National Institutes of Health and with biopharma companies to evaluate promising therapeutic approaches in multi-institutional clinical trials to improve the outcomes of blood and marrow transplantation and other cellular therapies for patients facing life-threatening blood disorders.
